The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic virus, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma.
 
Robert Hans Ingemar Andtbacka
Honoraria - Amgen; Merck/Schering Plough
Consulting or Advisory Role - Amgen; Merck/Schering Plough
Research Funding - Amgen (Inst); OncoSec (Inst); Takara Bio (Inst); Viralytics (Inst)
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Merck
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Merck
 
Sanjiv S. Agarwala
No Relationships to Disclose
 
Matthew H. Taylor
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Speakers' Bureau - Eisai
 
John T. Vetto
Employment - Genentech (I)
Stock and Other Ownership Interests - Roche (I)
Honoraria - Castle Biosciences
Speakers' Bureau - Castle Biosciences
 
Rogerio Izar Neves
Consulting or Advisory Role - Roche
Research Funding - Takara Bio (Inst)
 
Adil Daud
Stock and Other Ownership Interests - OncoSec
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; OncoSec; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer
 
Hung T. Khong
Stock and Other Ownership Interests - Apricus Biosciences; Aptose Biosciences; Array BioPharma; Exelixis; Immunomedics; KaloBios; MEI Pharma; TG Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Richard S. Ungerleider
No Relationships to Disclose
 
Maki Tanaka
Employment - Takara Bio
 
Kenneth F. Grossmann
Consulting or Advisory Role - Bristol-Myers Squibb (I); Castle Biosciences; Roche/Genentech